Blue Jet Healthcare, a specialty pharmaceutical and healthcare ingredients developer, is planning to launch its initial public offering (IPO) with the following details:
It’s important to note that the Blue Jet Healthcare IPO consists only of an offer-for-sale (OFS) component, with over 2.4 crore equity shares being offered by promoters. There is no fresh issue portion, which means that the entire proceeds from the IPO will go to the selling shareholders, specifically the Arora family, and the company will not raise any capital from the offering.
Investors can bid for a minimum of 43 equity shares and in multiples of 43 shares thereafter. Retail investors will have a minimum application size of Rs 14,878 (for 43 shares) and a maximum investment limit of Rs 1,93,414 (for 559 shares) as they cannot exceed an investment limit of Rs 2 lakh in the IPO.
Blue Jet Healthcare operates in three product categories: contrast media intermediates, high-intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs). It has specialized chemistry capabilities in contrast media intermediates and high-intensity sweeteners and caters to various customers, including GE Healthcare AS, Guerbet Group, Bracco Imaging SpA, Colgate-Palmolive (India), Unilever, Prinova US LLC, and MMAG Company.
In terms of revenue distribution, the European region contributed the most to its revenue from operations at 74.5% in FY23, followed by India at 14% and the USA at nearly 5%. The company reported a 5.5% YoY growth in revenue from operations in FY23, reaching Rs 721 crore. However, the net profit was down by 11.87% YoY to Rs 160 crore during the last fiscal year. In the quarter ending June FY24, the profit increased by 58.4% over the corresponding period last fiscal, and revenue from operations rose by 24.2% to Rs 179.5 crore in the same period.
The book running lead managers for the IPO are Kotak Mahindra Capital Company, ICICI Securities, and JP Morgan India.
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.